| Authors: |
Trapecar M; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Communal C; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Velazquez J; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Maass CA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Certara UK, Quantitative Systems Pharmacology, Sheffield, UK., Huang YJ; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Schneider K; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Wright CW; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Butty V; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; MIT BioMicro Center, Cambridge, MA, USA., Eng G; The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Yilmaz O; The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA., Trumper D; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA., Griffith LG; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Center for Gynepathology Research, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: griff@mit.edu. |
